STANDARD OPERATING PROCEDURE NO. CM
|
|
- Colin Tate
- 8 years ago
- Views:
Transcription
1 STANDARD OPERATING PROCEDURE NO. CM Version date: Effective Date: Replaces SOP No.: 1 5 January February Approved by: Date
2 No: CM Effective Date: 15 February 2013 Version Date: 15 January 2013 CONTENTS: 1. DEFINITIONS/REFERENCES PURPOSE SCOPE RESPONSIBILITIES PROCEDURES Creation of Clinical Management Plan Review of Clinical Management Plan Approval of Clinical Management Plan Revision and amending of Clinical Management Plan RELATED SOPs and GUDELINES APPENDICES/FORMS/SUPPORTING DOCUMENTS Appendix 1 Main Procedural Differences from Previous Version Appendix 2 Clinical Management Plan template Version 15/01/2013 Page 1 of 7 Confidential
3 No: CM Effective Date: 15 February 2013 Version Date: 15 January DEFINITIONS/REFERENCES Clinical Management Plan: A plan developed by the Project Manager or designee that identifies the overall contractual tasks and responsibilities and the processes of how each of those tasks and responsibilities will be accomplished. This may include, but is not limited to identification of all team members and associated clinical and data operations responsibilities. 2. PURPOSE To describe the procedures for the development, review, and approval of the Clinical Management Plan 3. SCOPE This process applies to all projects where the creation of a Clinical Management Plan is identified as a contractual deliverable. The Project Manager is responsible for ensuring that the Clinical Management Plan is developed, but may delegate tasks to other team members, as appropriate. 4. RESPONSIBILITIES Project Manager or designee: Develops the Clinical Management Plan with designated team members. Obtains approval from the Line Manager and other designated reviewers. Maintains the Clinical Management Plan. Distributes and explains the Clinical Management Plan to appropriate clinical team members. Documents distribution of designated sections to the investigational site, as appropriate. Line Manager: Reviews and approves all versions of the Clinical Management Plan. Distributes applicable sections of the Clinical Management Plan to the Sponsor in accordance with the scope of work, and approves distribution of applicable sections to the investigational site and any designated third party. Quality Assurance Manager: may be requested to review and approve relevant sections of the Clinical Management Plan, as appropriate, to ensure compliance with the documented scope of work, applicable SOPs and project instructions. 5. PROCEDURES 5.1 Creation of Clinical Management Plan The Project Manager or designee is responsible to: 1. Develops and oversees process 2. Determines, in conjunction with the sponsor, the template to be used for the Clinical Management Plan 3. Defines timelines for the development and review of the Project Management Plan 4. Notifies reviewers of upcoming review 5. Ensures draft Clinical Management Plan is developed within the specified timeline 6. Versions document with version date and version number (v1, v2, v3 etc.) 7. Forwards draft to the reviewers, providing timeline for review Version 15/01/2013 Page 2 of 7 Confidential
4 No: CM Effective Date: 15 February 2013 Version Date: 15 January 2013 The Project Manager or designee has options for creating the Clinical Management Plan; use the sample template as provided in this SOP, or create new document, or use Sponsor template, or a combination of options that may be described in the contract, or at the request of the Sponsor. Following items must be clearly documented in the Clinical Management Plan: The clinical and related contractual obligations described in the scope of work, the budget including assumptions, and the transfer of regulatory obligations. Detailed information on the clinical activities to be performed, including the communication plan, budget and assumptions, time lines and Clinical staff resources necessary to perform these activities References to applicable SOPs and project instructions Management and monitoring of the progress of the project scope of work according to contractual obligations, protocol specifications, GCPs and applicable regulations, SOPs and project instructions including, but not limited to, documentation of the following activities Quality control of clinical deliverables Identification and communication of out-of-scope activities Project-specific training of clinical team members Information dissemination, including updates of key documents (e.g., Investigator s Brochure) Coordination of the study completion process, including transfer of files/data and archiving Appendices such as the Monitoring Plan, Data Management Plan, or Safety Monitoring Plan may be generated as separate documents, if required by Sponsor/contract. 5.2 Review of Clinical Management Plan Project Manager or designee and the Line Manager shall identify the appropriate reviewers for the Clinical Management Plan, including a designated Clinical reviewer other than the PM or LM, which may include Quality Assurance Manager, Regulatory Manager or any other qualified reviewer(s). 5.3 Approval of Clinical Management Plan Project Manager or designee will incorporate Clinical reviewer s comments if any and he will return revised version to Clinical reviewers for final review, as appropriate. After final review Clinical reviewers should sign the appropriate approval page on Clinical Management Plan as a sign that the document has been approved. After final review and approval Project Manager or designee will send approved Clinical Management Plan to Sponsor for review if required by Sponsor and to the assigned Clinical Research Associate(s) for filing. 5.4 Revision and amending of Clinical Management Plan The Clinical Management Plan should be periodically reviewed and updated as the clinical study progresses and/or procedures change or tasks are added to the clinical Version 15/01/2013 Page 3 of 7 Confidential
5 No: CM Effective Date: 15 February 2013 Version Date: 15 January 2013 component of the study. It is acceptable for an individual section(s) of the Clinical Management Plan to be updated and distributed, provided that the required reviews and distribution are documented. The Project Management Plan will be amended based on changes in the scope of work and associated changes in the clinical budget. All amendments will be approved by the Line Manager, the Quality Assurance Manager or designated Clinical reviewer and any other reviewer(s). All approved versions of the Clinical Management Plan will be distributed to the PM for filing in the Project Management File, to appropriate Clinical team members and filed in the Central Clinical Study Files 6. RELATED SOPs and GUDELINES/SUPPORTING DOCUMENTS SOP CM.1Feasibility 7. APPENDICES/FORMS Appendix 1 Main Procedural Differences from Previous Version Appendix 2 Clinical Management Plan template Version 15/01/2013 Page 4 of 7 Confidential
6 No: CM Effective Date: 15 February 2013 Version Date: 15 January 2013 APPENDIX 1 Version 15/01/2013 Page 5 of 7 Confidential
7 No: CM Effective Date: 15 February 2013 Version Date: 15 January 2013 MAIN PROCEDURAL DIFFERENCES FROM THE PREVIOUS VERSION SOP # MODIFICATION Version Date CM draft Version 15/01/2013 Page 6 of 7 Confidential
8 No: CM Effective Date: 15 February 2013 Version Date: 15 January 2013 APPENDIX 2 Version 15/01/2013 Page 7 of 7 Confidential
9 EFFECTIVE DATE: VERSION NO.: *If amended, see section 8 and record details of changes from previous version Project Name: Project Number: Protocol Number: Sponsor Name: Address: Telephone No.: Fax No.: PREPARED BY: Name/Title: Office/Address: Telephone No.: Fax No.: PROJECT MANAGER APPROVED BY: NAME: SIGNATURE: DATE: PROJECT TEAM LEADER NAME: SIGNATURE: DATE: QUALITY ASSURANCE REVIEW NAME: SIGNATURE: DATE: REGULATORY AFFAIRS REVIEW NAME: SIGNATURE: DATE: OTHER REVIEW (SPECIFY) DISTRIBUTION LIST: Page 1 of 9
10 Purpose: To establish and document practical working methods for the clinical team based upon the protocol, scope of work, and contract. To facilitate the exchange and documentation of relevant information and expectations between Altiora and the Sponsor (INSERT name of Sponsor), and where appropriate the Investigator Scope: This clinical management plan applies to the (INSERT project name/reference) from the time that Altiora assumed contractual responsibility for clinical trial management until those contractual obligations are completed. TABLE OF CONTENTS Page 2 of 9
11 1.0 CLINICAL PROJECT/ACTIVITIES DESCRIPTION 2.0 CLINICAL SCOPE OF WORK, RESPONSIBILITIES AND PROCEDURES 2.1 DESCRIPTION OF ACTIVITIES 2.2 SPONSOR OBLIGATIONS 2.3 TRANSFER OF REGULATORY OBLIGATIONS 3.0 CLINICAL PROJECT BUDGET AND ASSUMPTIONS 4.0 CLINICAL PROJECT TIMELINE 5.0 CLINICAL PROJECT TEAM 5.1 ALTIORA CLINICAL PROJECT TEAM 5.2 SPONSOR CLINICAL CONTACTS 5.3 SITE/THIRD PARTY CONTACTS 6.0 CLINICAL COMMUNICATIONS PLAN 6.1 COMMUNICATIONS WITH SPONSOR 6.2 INTERNAL CLINICAL TEAM COMMUNICATIONS 6.3 COMMUNICATIONS WITH STUDY SITES 7.0 QUALITY PLAN 8.0 AMENDMENTS TO THE PROJECT AND CLINICAL MANAGEMENT PLAN 9.0 ATTACHMENTS 1.0 CLINICAL PROJECT/ACTIVITIES DESCRIPTION Page 3 of 9
12 A brief description (1-2 sentences, checklist or bulleted list) of the broad scope of the study (for example, phas e of study, indication, multi-center trial, countries involved, etc). 2.0 CLINICAL PROJECT SCOPE OF WORK, RESPONSIBILITIES AND PROCEDURES Reference where the overall list of responsibilities and referenced SOPs can be located, or provide details below: CLINICAL AND RELATED TASK LIST RESPONSIBLE ORGANIZATION RELEVANT SOPs (LIST PROCEDURE NUMBERS)* (To be customized for project) Site Identification Site Selection Visits Investigator Selection Site Initiation Visits Investigator s Meeting Regulatory Document Collection Investigational Product Shipment Blinding/Unblinding Monitoring Visits Closure Visits Adverse Event Reporting Data Management *If Altiora is responsible for a task and non Altiora s procedures are to be followed, list Sponsor SOP numbers here and see section 9 Attachments 2.1 DESCRIPTION OF ACTIVITIES Page 4 of 9
13 Provide a more detailed description or specific reference for tasks listed in Table 2.0 (above). The goal is to completely and unambiguously specify the requirements and procedures to be followed for each. Specify if the referenced document is included as an attachment (see section 9.0). Indicate if a specific activity is To be added or Not applicable. SPECIFIC ACTIVITY DESCRIPTION/REFERENCE 1. List of assigned sites and responsible clinical study monitors (current versions) 2. Description of team member training to include: SOP specific training if Altiora SOPs will no be used. Project specific training, by whom and how often. Where documentation of this training will be maintained. 3. List of all approved study specific forms (not including approved standard forms) and their intended use. 4. Process of clarifications for protocol interpretation and CRF completion (as applicable to protocol) Sponsor definition for screen failures Randomization process Procedures for obtaining protocol clarification/authorization of exceptions Patient unblinding procedures Definition for visit windows Prohibited concomitant medications Frequency of required site activities and maintenance of study equipment 5. Site monitoring visits Can include reference to study specific monitor s manual Frequency of visits Duration of visits, when known How deviations from the anticipated monitoring schedule will be recorded and approved by Sponsor Project specific guidelines for site visit reports and follow-up letters Time frame and method for submission and review of site visit reports to the CTL or designate 6. Timing of CRF submission relative to site visits (for example, Who sends CRFs where/crf Shipment procedures, CRFs sent as completed or collected by monitors after review at site visit). If ecrf is not in use. Page 5 of 9
14 7. Instructions for protocol deviation tracking by site and across project 8. Immediately Reportable Adverse Event (IRAE) Procedures: (as applicable to protocol) Sponsor definition of IRAE Sponsor definition of pre-existing condition Sponsor definition of a planned hospital admission Describe procedures for reporting IRAEs, including timelines to be met and contact details for the staff/offices/departments involved 9. Source Document Verification Procedures: (as applicable to protocol and scope of work) Percentage of source document checking Identification of key variables, if percentage of source document checking is different for key and non-key variables 10. Query Generation and Resolution Frequency of query generation and cross checks to be performed by data management Procedures for resolution of data clarifications and the documentation and filing requirements for data clarifications Standard procedure for documenting authorization of site personnel (other than PI) to resolve (approve and sign) data queries 11. Method and frequency of communicating and transmitting site specific regulatory updates to clinical study monitors where applicable 12. Investigational Product: (as applicable to protocol and scope of work) Frequency of Investigational Product accountability/reconciliation Handling, and shipping instructions for Investigational Product Investigational Product blinding procedures, if applicable Investigational Product relabeling instructions, if applicable Investigational Product recall instructions 13. Handling and shipping instructions for central or local laboratories, as applicable 14. Status reporting guidelines: (as applicable to Page 6 of 9
15 protocol and scope of work) Instructions for Site Instructions for CRAs Status Reports to Sponsor 15. Central Clinical Study File/Investigator Site File Project specific Investigator Site File contents (Table of Contents) Project specific Central Clinical Study File contents (Table of Contents) Reference manual for sites (Table of Contents) Instructions for completion of study logs 16. Procedures for Study Closure Archiving Instructions 2.2 SPONSOR OBLIGATIONS Reference or list below the sponsor obligations, in particular any obligations which would affect Altiora ability to meet time scales and budgets. Due Date: Due Date: Due Date: 2.3 TRANSFER OF REGULATORY OBLIGATIONS Only complete this section if there are any specific regulatory responsibilities that the sponsor has transferred to Altiora. Or where applicable, include a copy of the Transfer of Regulatory Obligations. 3.0 CLINICAL PROJECT BUDGET Provide information regarding the project budget and assumptions (issues that may need to specified include: fixed price, time and materials, consulting project with upper limit, incentive or penalty clause(s), version date and status of contract, specific work codes to be used, etc.). Reference can be made to the current version of the budget and assumptions being followed (see Section 9.0 Attachments). 4.0 CLINICAL PROJECT TIME LINE Identify all Sponsor and Altiora deliverables (as a minimum). Reference can be made to a separate detailed project plan (see Section 9.0 Attachments). TASK/MILESTONE START DATE END DATE 5.0 CLINICAL PROJECT TEAM Page 7 of 9
16 Identify principal Altiora and Sponsor Project Team members only. Reference can be made to a separate detailed project team/contact list (see Section 9.0 Attachments). 5.1 ALTIORA CLINICAL PROJECT TEAM NAME/ OFFICE/ADDRESS TITLE/ROLE TELEPHONE FAX 5.2 SPONSOR CLINICAL CONTACTS NAME/ OFFICE/ADDRESS TITLE/ROLE TELEPHONE FAX 5.3 SITE/THIRD PARTY CONTACTS (including Central IRB, central laboratory, etc. as applicable) NAME/ OFFICE/ADDRESS TITLE/ROLE TELEPHONE FAX 6.0 CLINICAL COMMUNICATIONS PLAN 6.1 COMMUNICATIONS WITH SPONSOR Specify the regular communications with the Sponsor (for example, weekly teleconference, monthly progress report, quarterly meetings, etc.) 6.2 INTERNAL CLINICAL PROJECT TEAM COMMUNICATIONS Specify internal communication channels (for example, Project Management and reporting structure, status reports to be circulated, etc.) 6.3 CLINICAL STUDY MONITOR COMMUNICATIONS WITH STUDY SITES Specify the frequency and method(s) of communicating with the study sites and documentation requirements. Page 8 of 9
17 7.0 QUALITY PLAN List the primary measures, checks and reviews to be performed for specified clinical deliverables. Specify any checks and review activities that will be performed by the Sponsor. 8.0 AMENDMENTS TO THE PROJECT AND CLINICAL MANAGEMENT PLAN Provide a summary list of all amendments made to the Clinical Management Plan. For each Amendment/Version issued, identify the specific section(s) updated in that version. Clearly summarize the major changes to be implemented including the effective date of the change(s). 9.0 ATTACHMENTS TO THE CLINICAL MANAGEMENT PLAN REFERENCE VERSION DATE/NO. Page 9 of 9
Subject: No. Page PROTOCOL AND CASE REPORT FORM DEVELOPMENT AND REVIEW Standard Operating Procedure
703 1 of 11 POLICY The Beaumont Research Coordinating Center (BRCC) will provide advice to clinical trial investigators on protocol development, content and format. Upon request, the BRCC will review a
More informationQuality Monitoring Checklist
Quality Monitoring Checklist Instructions: For each task below, the Quality Monitor indicates in the appropriate column if the Monitor accomplished the task by using the following codes Yes No N/A = Monitor
More informationINTERIM SITE MONITORING PROCEDURE
INTERIM SITE MONITORING PROCEDURE 1. PURPOSE The purpose of this SOP is to describe the interim monitoring procedures conducted at Institution, according to GCP and other applicable local regulations.
More informationTEMPLATE DATA MANAGEMENT PLAN
TEMPLATE DATA MANAGEMENT PLAN ICRIN (QM sub group) Version: XX Date: XXXXXXX Page 1 of 6 1.0 Document Ownership The Data Management Plan (DMP) will be initiated and subsequently owned by the Data Manager
More informationMarie-Claire Rickard, GCP & Governance Manager Rachel Fay, GCP & Governance Manager Elizabeth Clough, R&D Operations Manager
Standard Operating Procedures (SOP) for: Monitoring SOP 28 Version 7.0 Number: Number: Effective Date: 29 th November 2015 Review Date: 6 th January 2017 Author: Reviewer: Reviewer: Authorisation: Name
More informationThe Study Site Master File and Essential Documents
The Study Site Master File and Essential Documents Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 002 Version number: 1 Effective date: 01 June 2010
More informationCHANGE OF MONITOR AT STUDY SITE No: CM.8 01 02 Effective Date: 15 April 2013 Version Date: 15 March 2013
CONTENTS: 1. DEFINITIONS/REFERENCES 2. 2. PURPOSE 2. 3. SCOPE.2. 4. RESPONSABILITIES 2. 5. PROCEDURES...3. 5.1 Assessment of Need and Approval of Change of CRA... 3. 5.2 Project training......3. 5.3 Documentation
More informationNo. 706. Page 1 of 5. Issue Date 4/21/2014
Subject: ROUTINE MONITORING VISITS Standard Operating Procedure Prepared By: Beaumont Research Coordinating Center, Research Institute PURPOSE Prior Issue Date 8/15/2011 No. 706 Issue Date 4/21/2014 Page
More informationThe Monitoring Visit. Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis
The Monitoring Visit Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis Disclosure The information herein is not intended to
More informationROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:
More informationArchiving of Research Documentation
Suspension, Termination & Completion Standard Operating Procedure VERSION / REVISION: 2.0 EFFECTIVE DATE: 28 05 12 REVIEW DATE: 28 05 14 AUTHOR(S): CONTROLLER: APPROVED BY: Clinical Trials Manager; Recruitment
More informationDAIDS Appendix 2 No.: DWD-POL-DM-01.00A2. Data Management Requirements for Central Data Management Facilities
DAIDS Appendix 2 No.: DWD-POL-DM-01.00A2 Data Management Requirements for Central Data Management Facilities The following clinical trial data management requirements must be met in order to ensure the
More informationThe role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations
The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations Maria Luisa Paoloni OPBG Clinical & Research Services Monitoring and Responsible of monitoring:
More informationSection 1 Project Management, Project Communication/Process Design, Mgmt, Documentation, Definition & Scope /CRO-Sponsor Partnership
Section 1 Project Management, Project Communication/Process Design, Mgmt, Documentation, Definition & Scope /CRO-Sponsor Partnership PROJECT MANAGEMENT - SCOPE DEFINITION AND MANAGEMENT Understands the
More informationCONTROLLED DOCUMENT- DO NOT COPY STANDARD OPERATING PROCEDURE. STH Investigator
Research Department STANDARD OPERATING PROCEDURE STH Investigator Archiving of Essential Documentation Generated During Clinical Research SOP Number A127 Version Number V1.3 Effective Date Author Zoe Whiteley
More informationSTANDARD OPERATING PROCEDURE FOR RESEARCH. Management of Essential Documents and Trial Folders
STANDARD OPERATING PROCEDURE FOR RESEARCH Management of Essential Documents and Trial Folders Author Linda Ward Author s Job Title QA Coordinator Division Department Version number 2 Ref SOP/CLN/001/2
More informationData Management Unit Research Institute for Health Sciences, Chiang Mai University
Data Management Unit Research Institute for Health Sciences, Chiang Mai University Clinical Data Management is the process of handling data from clinical trials. The inherent goal of any clinical data
More informationICH CRA Certification Guide March 2009
ICH CRA Certification Guide March 2009 ICH CRA CERTIFICATION GUIDE... 1 GENERAL INFORMATION... 2 BENEFITS OF CERTIFICATION... 2 INDUSTRY RECOGNITION... 2 ABOUT THE EXAM... 2 CRA DEFINITION... 2 REQUIREMENTS
More informationGuidance on IRB Continuing Review of Research
NOTE: THIS GUIDANCE SUPERSEDES OHRP S JANUARY 15, 2007 GUIDANCE ENTITILED GUIDANCE ON CONTINUING REVIEW. CLICK HERE FOR THE JANUARY 15, 2007 GUIDANCE. Office for Human Research Protections Department of
More informationCLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE]
CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE] CONTRACT RESEARCH ORGANIZATION SPONSOR [NAME] [ADDRESS] 1 TABLE OF CONTENTS 1. Purpose 3 2. References 3 3. Study Roles and Responsibilities
More informationOrientation Manual for Clinical Research Coordinators
Orientation Manual for Clinical Research Coordinators Maine Medical Center Research Institute Page 1 of 19 Version 1 (2009) MAINE MEDICAL CENTER RESEARCH INSTITUTE Statement of Mission, Vision, Goals and
More informationStudy Start-Up SS-204.01. STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV)
Study Start-Up SS-204.01 STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV) Approval: Nancy Paris, MS, FACHE President and CEO 08 March 2012 (Signature and Date) Approval: Frederick M. Schnell,
More informationCNE Disclosures. To change this title, go to Notes Master
CNE Disclosures Successful Completion: Participants must complete an evaluation form to receive a certificate of completion Contact Hours: 1 contact hour is available to those who meet the successful completion
More informationWhat is Clinical Data Management
What is Clinical Data Management Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications, database systems to support collection,
More informationData Management & Case Report Form Development in Clinical Trials. Introduction to the Principles and Practice of Clinical Research.
Data Management & Case Report Form Development in Clinical Trials Introduction to the Principles and Practice of Clinical Research February 3, 2015 Marge Good, RN, MPH, OCN Nurse Consultant Division of
More informationManaging & Validating Research Data
Research Management Standard Operating Procedure ISOP-H02 VERSION / REVISION: 2.0 EFFECTIVE DATE: 01 03 12 REVIEW DATE: 01 03 14 AUTHOR(S): CONTROLLER(S): APPROVED BY: Information Officer; NBT Clinical
More informationHealth Canada s GCP Compliance Program Part 2. GCP Information Sessions November 2010
Your Health and Safety... Our priority Votre santé et votre Securité notre priorité Health Canada s GCP Compliance Program Part 2 GCP Information Sessions November 2010 Inspection Program Main objectives
More informationQUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH
QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH Martin Valania, Executive Director, Corporate QA and Compliance Introduction Pharmaceutical companies recognize the benefits of carefully managing
More informationCONTROLLED DOCUMENT. Uncontrolled Copy. RDS014 Research Related Archiving. University Hospitals Birmingham NHS Foundation Trust
University Hospitals Birmingham NHS Foundation Trust CONTROLLED DOCUMENT RDS014 Research Related Archiving CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Version Number: 1 Controlled Document
More information<name of project> Software Project Management Plan
The document in this file is adapted from the IEEE standards for Software Project Management Plans, 1058-1998, which conforms to the requirements of ISO standard 12207 Software Life Cycle Processes. Tailor
More informationClinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems
Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems to support collection, cleaning and management of subject
More informationClinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity
Clinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity Michelle Quaye Regulatory Manager, Advanced Therapy Trials University College London Overview The Principles of Good
More informationThis policy applies to all clinical research conducted at Beaumont Health System.
CLINICAL RESEARCH QUALITY AND PROCESS IMPROVEMENT PROGRAM 113 1 of 6 PURPOSE Prior The purpose of this policy is to provide an overview of the Clinical Research Quality and Process Improvement Program
More informationDocument Title: Project Management of Papworth Sponsored Studies
Document Title: Project Management of Papworth Sponsored Studies Document Number: SOP009 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G
More informationDepartment of Administration Portfolio Management System 1.3 June 30, 2010
E 06/ 30/ 2010 EX AM PL 1. 3 06/ 28/ 2010 06/ 24/ 2010 06/ 23/ 2010 06/ 15/ 2010 06/ 18/ 2010 Portfolio System 1.3 June 30, 2010 Contents Section 1. Project Overview... 1 1.1 Project Description... 1 1.2
More informationLaurie Shaker-Irwin, Ph.D., M.S. Co-Leader, Regulatory Knowledge and Research Ethics UCLA Clinical and Translational Science Institute
Laurie Shaker-Irwin, Ph.D., M.S. Co-Leader, Regulatory Knowledge and Research Ethics UCLA Clinical and Translational Science Institute Understand the protocol completely Recognize institutional polices
More informationEssential Documents for the Conduct of a Clinical Trial. Debra Dykhuis Associate Director RSO
Essential Documents for the Conduct of a Clinical Trial Debra Dykhuis Associate Director RSO Introduction Rationale for choosing this topic AHC movement toward setting GCP (Good Clinical Practice) guidelines
More informationHuman Research Protection Program Good Clinical Practice Guidance for Investigators Investigator & Research Staff Responsibilities
This Guidance Document is to ensure that investigators and research personnel recognize their responsibilities associated with the conduct of human subject research by outlining their responsibilities,
More informationThe Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial
The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial Clinical Research Operations & Regulatory Support (CRORS) Ann Glasse, RN, BSN, MBA Director-CRORS Objectives
More informationDHHS/NIH/OD/OIR/OHSRP 1/2/2015
DHHS/NIH/OD/OIR/OHSRP 1/2/2015 The audience for this course is Principal Investigators (PIs), investigators and Research Coordinators (RCs) serving on the study team of human clinical studies and trials.
More informationOE PROJECT CHARTER TEMPLATE
PROJECT : PREPARED BY: DATE (MM/DD/YYYY): Project Name Typically the Project Manager Project Charter Last Modified Date PROJECT CHARTER VERSION HISTORY VERSION DATE (MM/DD/YYYY) COMMENTS (DRAFT, SIGNED,
More informationSpeed to Market Abbott Nutrition Experience in Streamlining the Pediatric Clinical Research Process
Speed to Market Abbott Nutrition Experience in Streamlining the Pediatric Clinical Research Process Geraldine Baggs, Suzanne Monnin, Deborah Shye, Sue Zhang Abbott Nutrition Research & Development Abbott
More informationMedical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11
Effective Date: 09/12/06, 08/02/10, 3/2/11 Title: 1.0 OBJECTIVE: 1.1 This SOP describes the methods and policies for: Handling investigational drug Dispensing investigational drug 1.2. This procedure applies
More informationCOMMUNICATION MANAGEMENT PLAN Outline VERSION 0.0 STATUS: OUTLINE DATE:
COMMUNICATION MANAGEMENT PLAN Outline VERSION 0.0 STATUS: OUTLINE DATE: Document Information Document Title Amendment History Document Version Date Author/Reviewer Modifications 5/28/2014 Page i 2014 CSG
More informationTrial Delivery SOP 05 Trial Archiving
Gloucestershire Research and Development Consortium Standard Operating Procedure R&D SOP TD 05Trial Archiving Trial Delivery SOP 05 Trial Archiving IT IS THE RESPONSIBILITY OF ALL USERS OF THIS SOP TO
More informationHow To Write A Binder Tab
Tool Summary Sheet Tool: Extramural Essential Documents Binder/File Tabs Purpose: To provide an organizational framework and guidance for filing paper versions of essential study documents (or referencing
More informationOld Phase Description New Phase Description
Prologue This amendment of The FAA and Industry Guide to Product Certification (CPI Guide) incorporates changes based on lessons learned and supports the broader use of this guide by providing additional
More informationGOOD CLINICAL PRACTICE: CONSOLIDATED GUIDELINE
ICH E6 GCP: Consolidated Guideline: Investigator 1/7 Institutional Review Board Services ICH HARMONIZED TRIPARTITE GUIDELINE E6: GOOD CLINICAL PRACTICE: CONSOLIDATED GUIDELINE 4. INVESTIGATOR 4.1 Investigator's
More information1.0 INTRODUCTION 1.1 Overview
Guidance document for the writing of standard operating procedures (Taken from United States Environmental Protection Agency Guidance for Preparing Standard Operating Procedures (SOPs) EPA QA/G- 6 [EPA/600/B-
More informationEstablishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs)
Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs) Cornelia Kamp, MBA Executive Director Strategic Initiatives Tim Hackett Director
More informationSharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: shjohnson@email.com
SAMPLE CRA CV Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: shjohnson@email.com Education: Masters of Science, Healthcare Administration, Capital City University,
More informationCTMS Protocol Planning, Setup, and Maintenance
CTMS Protocol Planning, Setup, and Maintenance Updated: 09-Jul-2014 Updated: 09-Jul-2014 Page 2 of 22 Table of Contents Protocol Planning and Setup... 6 Protocol Set-Up Process... 6 Protocol Setup Requirements
More informationTRIAL MASTER FILE- SPONSORED
gsop-06-04 - Management of TMF for ENHT/ WHHT Sponsored CTIMPs Page 1 of 16 Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust TRIAL MASTER
More informationFormal FDA Meeting Request: Guidance and Template
Formal FDA Meeting Request: Guidance and Template ICTR Navigators July 23, 2011 Version 2.0 Page 1 of 20 1.0 Table of Contents Section Page 1.0 Table of Contents 2 2.0 Abbreviations 2 3.0 FDA Regulations
More informationPROJECT MANAGEMENT PLAN Outline VERSION 0.0 STATUS: OUTLINE DATE:
PROJECT MANAGEMENT PLAN Outline VERSION 0.0 STATUS: OUTLINE DATE: Project Name Project Management Plan Document Information Document Title Version Author Owner Project Management Plan Amendment History
More informationACDM GUIDELINES TO FACILITATE PRODUCTION OF A DATA HANDLING PROTOCOL
ACDM GUIDELINES TO FACILITATE PRODUCTION OF A DATA HANDLING PROTOCOL BACKGROUND The need was identified by the Electronic Data Transfer Special Interest Group (SIG) for each company or organisation to
More informationLGS Project Management Methodology
Page: 32 LGS Project Management Methodoy The LGS project management methodoy is integral to our overall delivery methodoy. Based on inpro, one of the LGS inspiration series documents, our methodoy is compliant
More informationGuidance for Industry Computerized Systems Used in Clinical Investigations
Guidance for Industry Computerized Systems Used in Clinical Investigations U.S. Department of Health and Human Services Food and Drug Administration (FDA) Office of the Commissioner (OC) May 2007 Guidance
More informationSOP Number: SOP-QA-20 Version No: 1. Author: Date: 1-9-15 (Patricia Burns, Research Governance Manager, University of Aberdeen)
Standard Operating Procedure: SOP Number: SOP-QA-20 Version No: 1 Author: Date: 1-9-15 (Patricia Burns, Research Governance Manager, University of Aberdeen) Approved by: Date: 1-9-15 (Professor Julie Brittenden,
More informationVersion history Version number Version date Effective date 01 dd-mon-yyyy dd-mon-yyyy 02 dd-mon-yyyy dd-mon-yyyy 03 (current) dd-mon-yyyy dd-mon-yyyy
Trial name: HOVON xxx yyy Sponsor: HOVON Version history Version number Version date Effective date 01 dd-mon-yyyy dd-mon-yyyy 02 dd-mon-yyyy dd-mon-yyyy 03 (current) dd-mon-yyyy dd-mon-yyyy QRMP authors
More informationCity of Raleigh Public Utilities Department. Wastewater EMS Manual
City of Raleigh Public Utilities Department Wastewater EMS Manual TABLE OF CONTENTS PAGE 2 Wastewater EMS Manual Table of Contents Management Direction 1) EMS Manual 2) Management Policy Planning 3) Process
More informationEssential Standard Operating Procedures Sample Templates Table of Contents
Essential Standard Operating Procedures Sample Templates Table of Contents Introduction Study Conduct and Good Clinical Practice 1: JHM Training/Certification Documentation 2: Delegation of Responsibility
More informationRECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING
RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING July 2006 TABLE OF CONTENTS Page 1. Introduction 2 2. Scope 2 3. Documents to be archived 2 4. Quality of essential documents 10 5.
More informationPROJECT MANAGEMENT PLAN TEMPLATE < PROJECT NAME >
PROJECT MANAGEMENT PLAN TEMPLATE < PROJECT NAME > Date of Issue: < date > Document Revision #: < version # > Project Manager: < name > Project Management Plan < Insert Project Name > Revision History Name
More informationResearch Study Close-down and Archiving Procedures
Title: Outcome Statement: Research Study Close-down and Archiving Procedures To inform researchers of the process for closing down research studies, retaining and storing research materials in the Trust.
More informationComprehensive Study Documents List (Biomedical Studies)
Comprehensive Study Documents List (Biomedical Studies) Investigators conducting human subjects research must maintain study documents in adherence to federal and state regulations, USC policies, and good
More informationDocument Number: SOP/RAD/SEHSCT/007 Page 1 of 17 Version 2.0
Standard Operating Procedures (SOPs) Research and Development Office Title of SOP: Computerised Systems for Clinical Trials SOP Number: 7 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013
More informationResearch Coordinator - PI s who have research coordinators or secretarial support can designate individuals to manage their IRB protocols in Mentor.
Mentor Online IRB System IRB s require lots of documentation and managing this process can get to be a burden for both investigators and the IRB committee and administrator. The Mentor IRB system is designed
More information11. Extension Potential Financial Benefits
11. Extension Potential Financial Benefits Estimating the financial value of using electronic health records (EHR) for clinical research is fraught with difficulties for a number of reasons, some of which
More informationClinical Data Management (Process and practical guide) Dr Nguyen Thi My Huong WHO/RHR/RCP/SIS
Clinical Data Management (Process and practical guide) Dr Nguyen Thi My Huong WHO/RHR/RCP/SIS Training Course in Sexual and Reproductive Health Research Geneva 2012 OUTLINE Clinical Data Management CDM
More informationDevelopment of Case Report Forms
Development of Case Report Forms Introduction to the Principles and Practice of Clinical Research February 12, 2013 Diane St. Germain, RN, MS Nurse Consultant Division of Cancer Prevention National Cancer
More informationBarnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA
Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA This presentation is the property of DynPort Vaccine Company LLC, a CSC company, and
More information1/30/2013. Agenda. Electronic Signatures/ Informed Consent
2013 UC Compliance & Audit Symposium Recordkeeping Matters: Part 11 Compliance Rachel Nosowsky ~ Acting Deputy General Counsel Rachel.Nosowsky@ucop.edu ~ (510) 987-9407 Agenda Electronic Signatures/Informed
More informationOrganization. Project Name. Project Overview Plan Version # Date
Project Overview Plan Template Organization Project Name Project Overview Plan Version # Date REVISION HISTORY VERSION # REVISION DATE COMMENT 1 APPROVALS: Authorized Signature DATE 2 Table of Contents
More informationSAMPLE POLICY/PROCEDURE TEMPLATE INVESTIGATIONAL DEVICE ACCOUNTABILITY
APPROVAL SIGNATURE (DEPARTMENT DIRECTOR OR PRINCIPAL INVESTIGATOR) DATE 1. INTRODUCTION This document describes (PI name or department) s policies/procedures for the receipt, storage, dispensing, reconciliation,
More informationDIRECTIVE NUMBER: 141.03.04.001 v2.0. SUBJECT: Correctional Integration Systems Change Management Plan
DEPARTMENT OF CORRECTION SUPPORT Management Services DIRECTIVE NUMBER: SUBJECT: Correctional Integration Systems Change PAGE NUMBER: 1 of 10 Adopted: 12-15-03 01.00.00. POLICY OF THE DEPARTMENT It is the
More informationWeb Meeting 12./13.12.2013: Study Close-out Procedures
SiLVER Study A prospective, randomized, open-labeled trial comparing sirolimuscontaining versus mtor-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
More informationSOP TD 01: Research Documentation and File Management
Gloucestershire Research and Development Consortium Standard Operating Procedure R&DSOP TD 01 Research Documentation and File Management SOP TD 01: Research Documentation and File Management IT IS THE
More informationStandard Operating Procedures
Standard Operating Procedures 5.5.1 Electronic Data Handling History Version Date Author Reason 1.1 18 th July 2007 B Fazekas New procedure 1.2 18 th August B Fazekas Changes ratified by MAB 2007 1.3 16
More informationProject Management Methodology
Project Management Methodology 1/6/2015 PAGE 1 OF 28 Version 2.0 Contents INTRODUCTION... 4 1. Overview... 4 PHASE 1 PROJECT INITIATION... 5 1. Governance Model... 6 2. Project Prioritization Process...
More informationCLINICAL DATA MANAGEMENT
J * Edition Practical Guide to CLINICAL DATA MANAGEMENT Susanne Prokscha (g) CRC Press Taylor Francis Croup London York CRC Press is an imprint of the Taylor Francis Croup, an buslness Preface Introduction
More informationCLINICAL RESEARCH PROTOCOL CHECKLIST
CLINICAL RESEARCH PROTOCOL CHECKLIST [taken from ICH GCP : Guidance for Industry, Good Clinical Practice: Consolidated Guidance, Revision 1 (R1) June 1996] ICH GCP, Section 6. CLINICAL TRIAL PROTOCOL AND
More informationDAIDS Bethesda, MD USA POLICY. Requirements for Clinical Quality Management Plans
NOTE: This policy and associated appendices have been reviewed for accuracy and updated to meet 508 compliance guidelines. DAIDS has clearly stated the minimum requirements for the CQMP and provided examples
More informationCentralized vs Onsite Monitoring:
Centralized vs Onsite Monitoring: A Sponsor s Balancing Act Applying a Risk-based Approach Introduction Since the August 2011 release of the draft guidance document by FDA on a risk-based approach to monitoring
More informationMRC. Clinical Trials. Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS. Medical Research Council
MRC Clinical Trials Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS 1998 Medical Research Council MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS 1998 MRC GUIDELINES FOR
More informationCONTRACT MANAGEMENT POLICY
CONTRACT MANAGEMENT POLICY Section Finance Approval Date 25/08/2014 Approved by Directorate Next Review Aug 2016 Responsibility Chief Operating Officer Key Evaluation Question 6 PURPOSE The purpose of
More informationPHASE 8: IMPLEMENTATION PHASE
PHASE 8: IMPLEMENTATION PHASE The Implementation Phase has one key activity: deploying the new system in its target environment. Supporting actions include training end-users and preparing to turn the
More informationGuidance for Industry Formal Meetings Between the FDA and Sponsors or Applicants
Guidance for Industry Formal Meetings Between the FDA and Sponsors or Applicants U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)
More informationClinical Data Management Overview
The 2 nd Clinical Data Management Training Clinical Data Management Overview Andrew Taylor ( 安 泰 乐 ), M.S. Head of Clinical Data Management August 30, 2010 Learning Objectives Overview of Process Related
More informationOperational aspects of a clinical trial
Operational aspects of a clinical trial Carlo Tomino Pharm.D. Coordinator Pre-authorization Department Head of Research and Clinical Trial Italian Medicines Agency Mwanza (Tanzania), June 11, 2012 1 Declaration
More informationInnovative Solutions Designed to Improve Operational Capacity, Efficiency and Effectiveness in Clinical Monitoring
Innovative Solutions Designed to Improve Operational Capacity, Efficiency and Effectiveness in Clinical Monitoring Brett Barber, Sr. Director, Strategic Resourcing Nicole Baker, Sr. Director, Strategic
More informationNew Investigator Collaborations and Interactions: Regulatory
Your Health and Safety... Our priority Votre santé et votre Securité notre priorité New Investigator Collaborations and Interactions: Regulatory NCIC Clinical Trials Group New Investigator Clinical Trials
More informationHollie Goddard Sr. IRB Coordinator McKesson Specialty Health
Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health We are responsible for acquiring, analyzing, and protecting medical information vital to providing quality patient care HIM professionals ensure
More informationRD SOP17 Research data management and security
RD SOP17 Research data management and security Version Number: V2 Name of originator/author: Dr Andy Mee, R&I Manager Name of responsible committee: R&I Committee Name of executive lead: Medical Director
More informationNEGOTIATING CLINICAL TRIAL BUDGETS. Debbie Williams R.N., C.C.R.C., C.R.A., A.B.N.
NEGOTIATING CLINICAL TRIAL BUDGETS Debbie Williams R.N., C.C.R.C., C.R.A., A.B.N. A.B.N. Amateur Budget Negotiator OVERVIEW Budget Types Analyzing the Protocol Negotiating the Contract Discussion / Tips
More informationDAIDS Bethesda, MD USA POLICY
Overview NIH policy requiring independent data and safety monitoring boards (DSMB) for all multicenter Phase III trials has existed since 1979; the most recent restatement was issued in 1998 (NIH Policy
More informationInformation Governance Policy
Author: Susan Hall, Information Governance Manager Owner: Fiona Jamieson, Assistant Director of Healthcare Governance Publisher: Compliance Unit Date of first issue: February 2005 Version: 5 Date of version
More informationStandard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL
Page 1 of 10 Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL SOP ID Number: Effective Date:01/08/2012 Version Number & Date of Authorisation: V02,
More informationUNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE
UNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES University of Leicester (UoL)
More informationPrincipal Investigator and Sub Investigator Responsibilities
Principal Investigator and Sub Investigator Responsibilities I. Purpose To define the roles and responsibilities of Principal Investigators conducting research at GRU. II. Definition The term Principal
More information